OneMedNet (ONMD) EBITDA (2021 - 2026)

OneMedNet (ONMD) has 6 years of EBITDA data on file, last reported at -$2.6 million in Q1 2026.

• On a quarterly basis, EBITDA fell 14.75% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$9.9 million, a 2.08% decrease from a year earlier, with the FY2025 full-year figure at -$9.7 million, down 0.65% from the prior year.
• EBITDA for Q1 2026 stood at -$2.6 million, up from -$3.1 million in the prior quarter.
• Over the last five years, EBITDA for ONMD reached as high as -$520025.0 in Q3 2022 and fell as low as -$5.8 million in Q4 2022.
• Historically, EBITDA has averaged -$2.1 million across 5 years, with a median of -$2.1 million in 2024.
• Across the five-year window, EBITDA slumped 72111.24% in 2022 and surged 67.74% in 2023, its largest moves.
• Year by year, EBITDA stood at -$5.8 million in 2022, then jumped by 67.74% to -$1.9 million in 2023, then sank by 45.4% to -$2.7 million in 2024, then declined by 13.48% to -$3.1 million in 2025, then climbed by 17.2% to -$2.6 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$2.6 million in Q1 2026, -$3.1 million in Q4 2025, and -$2.2 million in Q3 2025.